Compare RELX & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RELX | MET |
|---|---|---|
| Founded | 1903 | 1863 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Life Insurance |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.2B | 50.1B |
| IPO Year | N/A | N/A |
| Metric | RELX | MET |
|---|---|---|
| Price | $27.74 | $78.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | N/A | ★ $96.18 |
| AVG Volume (30 Days) | ★ 4.2M | 4.0M |
| Earning Date | 02-12-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.96% | 2.91% |
| EPS Growth | ★ 3.29 | N/A |
| EPS | 1.42 | ★ 4.71 |
| Revenue | $13,062,063,298.00 | ★ $77,084,000,000.00 |
| Revenue This Year | $6.02 | $1.96 |
| Revenue Next Year | $6.61 | $3.71 |
| P/E Ratio | $20.68 | ★ $16.54 |
| Revenue Growth | 2.48 | ★ 8.60 |
| 52 Week Low | $29.09 | $65.21 |
| 52 Week High | $56.33 | $87.39 |
| Indicator | RELX | MET |
|---|---|---|
| Relative Strength Index (RSI) | 11.13 | 52.87 |
| Support Level | $29.21 | $75.70 |
| Resistance Level | $29.83 | $81.67 |
| Average True Range (ATR) | 0.83 | 2.05 |
| MACD | -0.85 | 0.15 |
| Stochastic Oscillator | 2.05 | 55.45 |
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.